Promentis Pharmaceuticals, Inc.
4 clinical trials · Sponsor
◉ Watch Promentis Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal (NCT03887429) | Promentis Pharmaceuticals, Inc. | 2019-03-04 |
| A Study in Patients With Trichotillomania (NCT03797521) | Promentis Pharmaceuticals, Inc. | 2018-12-19 |
| Randomized, Double-Blind, Placebo-Controlled, MAD Study to Assess the Safety, Tolerability, and Pharmacokinetics of SXC 2023 (NCT03542435) | Promentis Pharmaceuticals, Inc. | 2018-04-26 |
| Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers (NCT03301298) | Promentis Pharmaceuticals, Inc. | 2017-09-11 |
Track Promentis Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.